<![CDATA[Alchemab Therapeutics 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=40129>Mon, 27 Apr 2026 15:33:24 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery]]>https://www.newswire.co.kr/newsRead.php?no=941507Wed, 23 Mar 2022 14:55:00 +0900<![CDATA[알케맙, 엔비디아 캠브리지-1 슈퍼컴퓨터 액세스 사업자로 선정… 머신러닝 통해 항체 연구 속도 내]]>https://www.newswire.co.kr/newsRead.php?no=941508Wed, 23 Mar 2022 14:55:00 +0900